// App-Quantinova.ai

3360 : EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngealcarcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop

Researchers

Presenter

  • Chang-Fu Yang

Principal Investigators

  • Guang-Da Yang

  • Tie-Jun Huang

  • Jia-Ling Huang

  • Chao-Nan Qian

  • Bi-Jun Huang

Medical Centers

  • Department of Cancer Chemotherapy, Gaozhou People's Hospital, Gaozhou, China

  • Department of Cancer Chemotherapy, Gaozhou People's Hospital, Gaozhou, China

  • Department of Nuclear Medicine, the Second People's Hospital of Shenzhen, Shenzhen, Shenzhen, China

  • Department of Pathology, Saint Barnabas Medical Center, New Jersey, NJ

  • State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Nasopharyngeal carcinoma

  • Solid malignancies

Biomarkers

  • Phosphatase and tensin homolog

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Cluster of Differentiation 44

  • Solute Carrier Family 22 Member 3

  • PI3K/AKT

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved